A compact SPR biosensor device for the rapid and efficient monitoring of gluten-free diet directly in human urine
Peláez Gutiérrez, Enelia Cristina (Institut Català de Nanociència i Nanotecnologia)
Estévez, M. Carmen (Institut Català de Nanociència i Nanotecnologia)
Domínguez, Remedios (Biomedal S.L)
Sousa, Carolina (Universidad de Sevilla)
Cebolla, Angel (Biomedal S.L)
Lechuga, Laura M (Institut Català de Nanociència i Nanotecnologia)

Títol variant:	A compact plasmonic biosensor device for the rapid and efficient monitoring of gluten free diet directly in human urine
Data:	2020
Resum:	Celiac disease (CD) is a chronic autoimmune disorder induced in genetically susceptible individuals by the ingestion of gluten from wheat, rye, barley, or certain varieties of oats. A careful diet follow-up is necessary to avoid health complications associated with long-term gluten intake by the celiac patients. Small peptides (GIP, gluten immunogenic peptides) derived from gluten digestion, which are excreted in the urine and feces, have emerged as promising biomarkers to monitor gluten intake. We have implemented a simple and sensitive label-free point-of-care (POC) device based on surface plasmon resonance for the direct detection of these biomarkers in urine. The assay employs specific monoclonal antibodies and has been optimized for the detection of the 33-mer α2-gliadin, known as the main immunogenic peptide of wheat gluten, and for the detection of GIP. Direct detection in undiluted urine has been accomplished by using biosensing chips containing a robust and stable biorecognition layer, obtained after carefully optimizing the biofunctionalization protocol. Excellent limits of detection have been reached (1. 6-4. 0 ng mL using mAb G12 and A1, respectively), which ensures the detection of gluten peptides even when the gluten intake is around the maximum tolerable amount in the digestive tract (< 50 mg) for celiac individuals. No sample pretreatment, extraction, or dilution is required, and the analysis takes less than 15 min. The assays have excellent reproducibility‚ as demonstrated by measuring spiked urine samples containing the same target concentration using different biofunctionalized chips prepared and stored at different periods of time (i. e. , CV% of 3. 58% and 11. 30%, for G12- and A1-based assays, respectively). The assay has been validated with real samples. These features pave the way towards an end-user easy-to-handle biosensor device for the rapid monitoring of gluten-free diet (GFD) and follow-up of the health status in celiac patients.
Ajuts:	Ministerio de Economía y Competitividad SEV-2017-0706
Drets:	Tots els drets reservats.
Llengua:	Anglès
Document:	Article ; recerca ; Versió sotmesa a revisió
Matèria:	POC device ; Gluten immunogenic peptides ; 33-mer gliadin peptide ; Celiac disease ; Urine ; Gluten-free diet
Publicat a:	Analytical and bioanalytical chemistry, Vol. 412 (April 2020) , p. 6407-6417, ISSN 1618-2650

DOI: 10.1007/s00216-020-02616-6

Preprint 32 p, 2.4 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències > Institut Català de Nanociència i Nanotecnologia (ICN2)
Articles > Articles de recerca
Articles > Articles publicats